886-P: Smoking and Cessation Patterns of People with Diabetes

Turkey has the highest prevalence of diabetes and smoking in Europe (diabetes 13.7%; smoking 44% of men and 18% of women). Smokers with diabetes have a heightened risk of morbidity and mortality. The routine assessment of tobacco use as an essential to prevent smoking or encourage cessation.^(ADA,2018) At present, little is known about the cessation services provided by diabetes professionals to their patients in Turkey. A nationwide survey was conducted to gather data on this topic. Utilizing a point prevalence methodology, data was collected from 24 provinces around Turkey. Diabetes nurses from 172 diabetes centers were invited to complete a survey (response rate 28.4%). The survey included 11 questions; patient demographics, type and duration of diabetes, patient smoking status, smoking and cessation behaviors after diabetes diagnosis, cessation recommendation from HCP. The survey with instruction + video about how to complete the survey were sent via e-mail and phone messages to the nurses. Surveys were completed on one clinic day between December 3-7,2018 to all diabetes patients. (Ethics 2018.229.IRB3.162) of patients (n=779), 59,4% is women; 86,3% has type 2 diabetes. Mean duration of diabetes 10,39 years; mean age is 54,97 years. Smoking prevalence is 26,8%. The highest smoking prevalence is 40,4% in men, while 19,0% in women. Of patients,19,3% smokes 10 cigarettes or more in a day; 26,2% is quitter while 10,7% of them quit after diabetes diagnosis; 80,1% believes any amount of smoking is harmful. As opposed to, 7.4% of patients believes 1-2 cigarettes in a day is not harmful, 6,0% believes that there is no relation between smoking and diabetes. Only 11,8% of smokers has quitting advice from HCP relating the risk of smoking for diabetes control. This nation-wide survey reveals the first data on smoking and cessation in Turkish people with diabetes. Findings shows that patients are not aware of the harm of tobacco. Behavior-based smoking cessation trainings will be applied for diabetes professionals in the light of these early data.